Actos – FDA warns of Increased Risk of Bladder Cancer

August 29, 2011

Actos (pioglitazone) lawyers within our firm are reviewing potential cases against the Actos manufacturer after the FDA warned that Actos use is linked to an Increased Risk of Bladder Cancer. The FDA Actos findings can be read here:

Actos, known as Pioglitazone has been sold under the brand name Actos or in combination with metformin as Actoplus Mext XR and glimepiride as Duetact.  The drug is intended to treat diabetes.

If you or a loved on has been diagnosed with Bladder Cancer and have taken Actos, a diabetes medication, please contact us for free legal advice and free legal Actos information concerning the potential for an Actos lawsuit.  At Fears | Nachawati, our Actos lawyers are experienced defective drug lawyers.  Call us at 1.866.545.8364 or by email at

More Blog Posts


Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law


With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consultation

Live Chat (Online Now)